v3.26.1
Stockholders’ equity (Tables)
12 Months Ended
Dec. 31, 2025
Equity [Abstract]  
Schedule of option activity

The following table summarizes the Company’s employee and non-employee stock option activity under the 2022 Omnibus Plan for the following periods:

 

   Number of Shares   Weighted Average Exercise Price Per Share   Weighted Average Remaining Contractual Life (Years)   Aggregate Intrinsic Value 
                 
Outstanding as of December 31, 2023   1,215,001   $5.29    8.7   $ 
Granted   3,599,000    1.15         
Expired   (268,886)   5.05         
Forfeitures   (309,449)   4.68         
Outstanding as of December 31, 2024   4,235,666   $1.83    9.2   $135,200 
Granted   3,230,170    1.44         
Exercised   (863,595)   

1.03

         
Expired   (429,999)   4.53         
Forfeitures   (100,000)   

1.19

         
Outstanding as of December 31, 2025   6,072,242    1.34    9.4    1,067,000 
Exercisable as of December 31, 2025   6,018,075   $1.34    9.4   $1,042,000 
Schedule of fair value options issued

Key assumptions used to value stock options during the years ended December 31, 2025 and 2024 are as follows:

 

   Years Ended December 31,  
    2025    2024 
Risk-free interest rate   3.70-4.20%   3.49-4.56%
Expected volatility   186.0-210.0%   58.46-152.45%
Exercise Price  $

1.18 - $1.45

   $0.71 - $1.57 
Expected term (years)   

5.0-5.4 years

    5.0-5.5 years 
Dividend yield        
Schedule of restricted stock unit activity

The following is RSU activity during the year ended December 31, 2025:

 

   Number of Restricted Shares 
Unvested as December 31, 2024   500,000 
Granted   125,000 
Expired and forfeitures    
Vested   (625,000)
Unvested as December 31, 2025    
Schedule of warrant activity

 

           Weighted     
       Weighted   Average     
   Number of   Average
Exercise
   Remaining
Contractual
   Aggregate 
   Warrants   Price   Term (Years)   Intrinsic Value 
Balance Outstanding as December 31, 2024   1,763,570   $3.88    3.60   $    
Granted                
Exercised                
Balance outstanding as December 31, 2025   1,763,570   $3.88    2.60   $ 
Exercisable, December 31, 2025   1,763,570   $3.88    2.60   $